These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21155685)

  • 1. Use of calcium folinate in the management of accidental methotrexate ingestion in two dogs.
    Lewis DH; Barfield DM; Humm KR; Goggs RA
    J Am Vet Med Assoc; 2010 Dec; 237(12):1450-4. PubMed ID: 21155685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric case of accidental oral overdose of methotrexate.
    Gibbon BN; Manthey DE
    Ann Emerg Med; 1999 Jul; 34(1):98-100. PubMed ID: 10382002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to initial treatment of low and intermediate risk gestational trophoblastic disease with methotrexate and folinic acid.
    Tonanont M; Inthasorn P; Boriboonhirunsarn D; Wongthiraporn W; Suphanit I
    J Med Assoc Thai; 2005 Oct; 88(10):1349-54. PubMed ID: 16519378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
    Rhee MS; Coward JK; Galivan J
    Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase.
    Nichol CA; Cavallito JC; Woolley JL; Sigel CW
    Cancer Treat Rep; 1977 Jul; 61(4):559-64. PubMed ID: 301777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
    Kickinger W; Ritschl P; Kotz R
    Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium leucovorin - folinic acid rescue.
    Drug Ther Bull; 1978 Feb; 16(3):11-2. PubMed ID: 305337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute poisoning with methotrexate used as an abortifacient: description of 2 cases].
    Alfaro J; Von Mühlenbrock R; Burgos N; Valdés E; Gana C; Conte G; Araos D; Plate L
    Rev Med Chil; 2000 Mar; 128(3):315-8. PubMed ID: 10962874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors.
    Duch DS; Lee CL; Edelstein MP; Nichol CA
    Mol Pharmacol; 1983 Jul; 24(1):103-8. PubMed ID: 6865919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavitary therapy of murine ovarian cancer with cis-diamminedichloroplatinum(II) and 10-ethyl-10-deazaaminopterin incorporating systemic leucovorin protection.
    Sirotnak FM; Schmid FA; DeGraw JI
    Cancer Res; 1989 Jun; 49(11):2890-3. PubMed ID: 2785847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and significance of D-methotrexate as a contaminant of commercial methotrexate.
    Cramer SM; Schornagel JH; Kalghatgi KK; Bertino JR; Horváth C
    Cancer Res; 1984 May; 44(5):1843-6. PubMed ID: 6713386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of the reversal of methotrexate toxicity in rodents.
    Kisliuk RL; Tattersall MH; Gaumont Y; Pastore EJ; Brown B
    Cancer Treat Rep; 1977 Jul; 61(4):647-50. PubMed ID: 301779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate.
    Queener SF
    J Protozool; 1991; 38(6):154S-157S. PubMed ID: 1840146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1.
    Takeuchi A; Masuda S; Saito H; Hashimoto Y; Inui K
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1034-9. PubMed ID: 10869408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin B12 as a regulator and methotrexate as an antagonist of folic acid metabolism. Pathophysiologic and clinical aspects].
    Sauer H
    Fortschr Med; 1983 Apr; 101(15):705-10. PubMed ID: 6602086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.